The "Subcutaneous" Pivot: How 2026 is Moving Cancer...

adicionou um novo artigo Health

2026-02-12 05:38:01 -

The "Subcutaneous" Pivot: How 2026 is Moving Cancer Treatment Out of the Hospital.

A major shift in the 2026 global industry is the record-breaking dominance of "APAC-Based Bioproduction." This year, to cater to the skyrocketing global demand for affordable biologics, the Oncology Biosimilars Market has seen over 60% of new developers based in the Asia-Pacific region, specifically in South Korea, India, and China. This level of "Geographic Centralization" is the new gold...

0 Comentários 0 Compartilhamentos 83 Visualizações 0 Anterior